http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e14a0429f0e2921dd1701f8b6c439097
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Earle |
| name | Craig C Earle Craig C. Earle |
| given-name | Craig C Craig C. |
| organization-name | Oreofe O. Odejide, Angel M. Cronin, Nolan B. Condron, Sean A. Fletcher, James A. Tulsky, Gregory A. Abel, Dana-Farber Cancer Institute; James A. Tulsky, Brigham and Women’s Hospital, Boston, MA; and Craig C. Earle, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. From the Johns Hopkins School of Medicine and Bloomberg School of Public Health, Baltimore, MD; and the Institute for Clinical Evaluative Sciences, Toronto, Canada. Authors' Affiliations: 1Ontario Institute for Cancer Research and Cancer Care Ontario; 2Department of Family and Community Medicine, University of Toronto; 3Institute of Clinical Evaluative Sciences, Toronto, Ontario, Canada; and 4National Coalition for Cancer Survivorship, Silver Spring, Maryland; Authors' Affiliations: 1Ontario Institute for Cancer Research and Cancer Care Ontario; 2Department of Family and Community Medicine, University of Toronto; 3Institute of Clinical Evaluative Sciences, Toronto, Ontario, Canada; and 4National Coalition for Cancer Survivorship, Silver Spring, Maryland Center for Outcomes and Policy Research, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts Health services researcher and medical oncologist specializing in gastrointestinal malignancies. He is director of the health services research program for Cancer Care Ontario and the Ontario Institute for Cancer Research, a senior scientist at the Institute for Clinical Evaluative Sciences, and a professor in the Department of Medicine at the University of Toronto, in Toronto, Ontario. From the Ontario Institute for Cancer Research; Odette Cancer Centre; Institute for Clinical Evaluative Sciences, Toronto, Ontario; and Dana-Farber Cancer Institute, Boston, MA. Stanford Cancer Institute, Stanford, CA; National Coalition for Cancer Survivorship, Silver Spring, MD; and Institute for Clinical Evaluative Sciences, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada Division of Medical Oncology, British Columbia Cancer Agency University of British Columbia Vancouver Canada Department of Medicine, University of Toronto, Ontario, Canada Jeffrey S. Hoch, Cancer Care Ontario and St Michael's Hospital; David C. Hodgson, Princess Margaret Hospital; and Craig C. Earle, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. Sunnybrook Health Sciences Center, Toronto, Ontario, Canada; Dana Farber Cancer Institute, Boston, MA; and Stanford University, Stanford, CA Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada From the Divisions of Population Sciences and Psychosocial Oncology and Palliative Care, Department of Medical Oncology, Dana-Farber Cancer Institute; Department of Health Care Policy, Harvard Medical School; and Division of General Medicine and Department of Psychiatry, Brigham & Women’s Hospital, Boston, MA Department of Medicine University of Toronto Toronto Ontario Canada; Institute for Clinical Evaluative Sciences Toronto Ontario Canada; Sunnybrook Odette Cancer Center Toronto Ontario Canada; Ontario Institute for Cancer Research Toronto Ontario Canada ICES Toronto Ontario Canada Sunnybrook Odette Cancer Centre Toronto Ontario Canada Dana-Farber Cancer Institute, Boston, Massachussetts, USA Jennifer A. Chan, Craig C. Earle, Pankaj Bhargava, Peter C. Enzinger, Jeffrey A. Meyerhardt, Charles S. Fuchs, and Matthew H. Kulke, Dana-Farber Cancer Institute; Jennifer A. Chan, Craig C. Earle, Pankaj Bhargava, Peter C. Enzinger, Jeffrey A. Meyerhardt, Charles S. Fuchs, and Matthew H. Kulke, Brigham and Women's Hospital; Keith Stuart and Rebecca Miksad, Beth Israel Deaconess Medical Center; Jeffrey W. Clark and Lawrence Blaszkowsky, Massachusetts General Hospital; Hui Zheng, Biostatistics Center,... ICES, Toronto, Ontario, Canada.; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. From the Department of Health Care Policy, Harvard Medical School; and Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA; and Metro Center for Urban Education, Steinhardt School of Education, New York University, New York, NY. Institute for Clinical Evaluative Sciences Toronto Ontario Canada Institute for Clinical Evaluative Sciences, Toronto, ON, Canada Erica L. Mayer, Bridget A. Neville, Ann H. Partridge, and Eric P. Winer, Dana-Farber Cancer Institute; Adrienne B. Gropper, Harvard Medical School, Boston, MA; Danielle B. Cameron, University of Miami Miller School of Medicine, Boca Raton, FL; and Craig C. Earle, Institute of Clinical Evaluative Sciences, Toronto, Ontario, Canada. 1ICES, Toronto, Ontario;; 6Division of Medical Oncology, Department of Medicine, and Faculty of Medicine University of Toronto Toronto Canada; Institute for Clinical Evaluative Sciences Toronto Canada Institute for Clinical Evaluative Sciences Toronto Ontario Canada; Canadian Centre for Applied Research in Cancer Control (ARCC) Toronto Ontario Canada; Ontario Institute for Cancer Research Toronto Ontario Canada; Cancer Care Ontario Toronto Ontario Canada From the Center for Medical Decision Making, Department of Public Health, Erasmus MC, Rotterdam, the Netherlands; and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA Craig C. Earle, Ontario Institute for Cancer Research, Toronto, Ontario, Canada; and Patricia A. Ganz, University of California at Los Angeles Schools of Medicine and Public Health, and Jonsson Comprehensive Cancer Center, Los Angeles, CA. Faculty of Medicine University of Toronto Toronto Ontario Canada; Sunnybrook Health Sciences Centre Toronto Ontario Canada; Institute for Clinical Evaluative Sciences Toronto Ontario Canada ICES Toronto Ontario Canada; Division of Medical Oncology Odette Cancer Centre Sunnybrook Health Sciences Centre Toronto Ontario Canada Craig C. Earle is director of the Health Services Research Program at Cancer Care Ontario and the Ontario Institute for Cancer Research, in Toronto. Institute for Clinical and Evaluative Sciences Sunnybrook Health Sciences Centre Toronto From the Division of Population Sciences and Division of Psychosocial Oncology and Palliative Care, Department of Medical Oncology, Dana-Farber Cancer Institute; Department of Psychiatry/Institute for Health Policy, Massachusetts General Hospital; Division of General Medicine, and Department of Psychiatry, Brigham and Women’s Hospital; and Department of Health Care Policy, Harvard Medical School, Boston, MA. Cancer Care Ontario, Ontario Institute for Cancer Research, and the Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. Jennifer W. Mack, Angel Cronin, Nathan Taback, and Jane C. Weeks, Dana-Farber Cancer Institute; Jennifer W. Mack, Boston Children's Hospital; Nancy L. Keating and Haiden A. Huskamp, Harvard Medical School; Nancy L. Keating, Brigham and Women's Hospital, Boston, MA; Jennifer L. Malin, Greater Los Angeles Veterans Administration Health Care System and University of California at Los Angeles, Los Angeles, CA; and Craig C. Earle, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada From the Harvard Radiation Oncology Program, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Boston, MA From the Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute; Department of Health Care Policy, Harvard Medical School; and the Division of General Medicine, Brigham and Women's Hospital, Boston, MA From the British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. Ontario Institute for Cancer Research, Toronto, Canada Ontario Institute for Cancer Research, Toronto, Ontario, Canada. ICES, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada University of Toronto, Toronto, Ontario, Canada; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Ontario Institute for Cancer Research, Toronto, Ontario, Canada; ICES, Toronto, Ontario, Canada Claire F. Snyder, Johns Hopkins School of Medicine; Claire F. Snyder, Kevin D. Frick, and Robert J. Herbert, Johns Hopkins Bloomberg School of Public Health; Claire F. Snyder, Kevin D. Frick, Amanda L. Blackford, Antonio C. Wolff, and Michael A. Carducci, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD; Bridget A. Neville, Consultant, Boston, MA; and Craig C. Earle, Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. Alisha Kassam, Kimberley Widger, Adam Rapoport, Katherine Nelson, and Sumit Gupta, The Hospital for Sick Children; Alisha Kassam, Kimberley Widger, Adam Rapoport, and Sumit Gupta, University of Toronto; Rinku Sutradhar, Jason D. Pole, Craig C. Earle, and Sumit Gupta, Institute for Clinical Evaluative Sciences; Adam Rapoport, Emily’s House Children’s Hospice; and Jason D. Pole, Pediatric Oncology Group of Ontario, Toronto; Alisha Kassam, Southlake Regional Health Centre, Newmarket, Ontario, Canada; and... Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA Dana-Farber Cancer Institute, Boston, MA Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada Ontario Institute for Cancer Research, Toronto, ON, Canada. ICES, Toronto, Ontario, Canada; Canadian Partnership Against Cancer, Toronto, Ontario, Canada; Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada Division of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada; Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada 2Cancer Program – Evaluative Clinical Sciences, and; 5ICES, Toronto, Ontario;; 8Division of Medical Oncology, Odette Cancer Centre – Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. Outcome Sciences, Cambridge, MA; American Society of Clinical Oncology, Alexandria, VA; Ontario Institute for Cancer Research; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada; Oncology Hematology Care, Cincinnati, OH Department of Medicine University of Toronto Toronto Ontario Canada; Odette Cancer Centre Sunnybrook Health Sciences Centre Toronto Ontario Canada; Ontario Institute for Cancer Research Toronto Ontario Canada; Institute for Clinical Evaluative Sciences Toronto Ontario Canada Ottawa Regional Cancer Centre, University of Ottawa, and the Ontario Cancer Treatment and Research Foundation, Ottawa, Ontario, Canada. Division of Population Sciences, Dana-Farber Cancer Institute, Boston Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada Alexi A. Wright, Dana-Farber Cancer Institute; Alexi A. Wright, Laura A. Hatfield, and Nancy L. Keating, Harvard Medical School; Nancy L. Keating, Brigham and Women's Hospital, Boston, MA; and Craig C. Earle, Cancer Care Ontario and Ontario Institute for Cancer Research, Toronto, Ontario, Canada. ICES Toronto Ontario Canada; Department of Medicine University of Toronto Toronto Ontario Canada Division of Hematology/Medical Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada;; Institute for Clinical Evaluative Sciences, Toronto, Canada; From the Center for Outcomes and Policy Research, Departments of Adult Oncology and Biostatistical Science, Dana-Farber Cancer Institute; and the Program on the Economic Evaluation of Medical Technology, Center for Risk Analysis, Harvard School of Public Health, Boston, MA. Ontario Institute of Cancer Research, Toronto, Ontario, Canada From the Center for Outcomes and Policy Research, Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA. 1ICES, Toronto, Ontario;; 10Department of Medicine, and Department of Medicine, University of Toronto, Toronto, Ontario, Canada Nicole Mittmann, Sunnybrook Research Institute, Cancer Care Ontario, and University of Toronto; Craig C. Earle, Ontario Institute for Cancer Research; Craig C. Earle, Stephanie Y. Cheng, and Farah Rahman, Institute for Clinical Evaluative Sciences; Soo Jin Seung, Health Outcomes and PharmacoEconomic (HOPE) Research Centre, Sunnybrook Research Institute, Toronto; and Jim A. Julian and Mark N. Levine, Juravinski Cancer Centre, McMaster University, and Ontario Clinical Oncology Group, Hamilton, Ontario,... From the Institute for Clinical Evaluative Sciences and University of Toronto, Toronto, Ontario, Canada; Department of Statistics, Harvard University; Division of General Medicine, Brigham and Women's Hospital; Department of Health Care Policy, Harvard Medical School; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Pharmacy Practice and Science, University of Iowa, Iowa City, IA; and Jonsson Comprehensive Cancer Center, Los Angeles, CA. Ontario Institute for Cancer Research Toronto Ontario Canada From the Department of Adult Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA. ICES London and Toronto, Ontario, Canada; Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada IC/ES, Toronto, Canada;; Sunnybrook Health Sciences Centre, Toronto, Canada From the Dana-Farber Cancer Institute; and the Massachusetts General Hospital, Boston, MA. Ontario Institute for Cancer Research Toronto Canada; Institute for Clinical Evaluative Sciences Toronto Canada From the Department of Radiation Oncology and Center for Outcomes and Policy Research, Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA From the Division of Population Sciences, Center for Outcomes and Policy Research, Breast Oncology Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Institute for Clinical Evaluative Sciences, Toronto, ON, Canada M4N 3M5 From the Center for Outcomes and Policy Research, Department of Adult Oncology, and Department of Biostatistical Science, Dana-Farber Cancer Institute, and Program on the Economic Evaluation of Medical Technology, Center for Risk Analysis, Harvard School of Public Health, Boston, MA. From the Division of Pharmacoepidemiology, Department of Medicine; and Division of General Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA From the Center for Clinical Decision Sciences, Department of Public Health, Erasmus MC, Rotterdam, the Netherlands; and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA Institute for Clinical Evaluative Sciences and Ontario Institute for Cancer Research, Toronto, Ontario, Canada ICES, Ontario, Canada Johns Hopkins University Carey Business School; Johns Hopkins University School of Medicine; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada Sunnybrook Health Sciences Centre; University of Toronto; Ontario Institute for Cancer Research; and Institute for Clinical Evaluative Sciences, Toronto, Canada Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA Cancer Care Ontario Toronto Canada; Ontario Institute for Cancer Research Toronto Canada; Institute for Clinical Evaluative Sciences Toronto Canada Kathleen M. Fairfield, Kimberly Murray, F. Lee Lucas, Heidi R. Wierman, and Laurie Small, Maine Medical Center, Portland, ME; Craig C. Earle, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; and Edward L. Trimble and Joan L. Warren, National Cancer Institute, Bethesda, MD. From the Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA eCanadian Partnership Against Cancer, Toronto; Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, Massachusetts Ontario Institute for Cancer Research Toronto ON Canada; Institute for Clinical Evaluative Sciences Toronto ON Canada Mary Beth Landrum, Nancy L. Keating, Elizabeth B. Lamont, and Barbara J. McNeil, Harvard Medical School; Nancy L. Keating and Barbara J. McNeil, Brigham and Women's Hospital; Elizabeth B. Lamont, Massachusetts General Hospital Cancer Center; Lawrence Shulman, Jennifer R. Brown, and Michael Rabin, Dana-Farber Cancer Institute, Boston; Samuel R. Bozeman, Abt Associates, Cambridge, MA; Steven H. Krasnow, Washington, DC Veterans Affairs Medical Center, Washington, DC; and Craig C. Earle, Sunnybrook Health... Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Medical Oncology & Hematology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; ICES, Toronto, Ontario, Canada Dana-Farber Cancer Institute, Boston, Mass, USA. Division of Hematology/Medical Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada Division of Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada;; ICES, Toronto, Canada;; Ontario Institute for Cancer Research, Toronto, Canada ICES, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Canadian Partnership Against Cancer, Toronto, Ontario, Canada Stanford University, Stanford, CA; and Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada Canadian Centre for Applied Research in Cancer Control (ARCC), Vancouver, British Columbia, Canada; Ontario Institute for Cancer Research, Toronto, Ontario, Canada Department of Medicine, Division of Medical Oncology, Sunnybrook Health Sciences Centre, University of Toronto , Toronto, ON, Canada; Temerty Faculty of Medicine, University of Toronto , Toronto, ON, Canada; Canadian Partnership Against Cancer , Toronto, ON, Canada Canadian Partnership Against Cancer, Toronto, ON, Canada Kimberley Widger, Rinku Sutradhar, Adam Rapoport, Alisha Kassam, and Sumit Gupta, University of Toronto; Kimberley Widger, Adam Rapoport, Alisha Kassam, Katherine Nelson, and Sumit Gupta, The Hospital for Sick Children; Rinku Sutradhar, Ying Liu, Craig C. Earle, Jason D. Pole, and Sumit Gupta, Institute for Clinical Evaluative Sciences; Adam Rapoport, Emily’s House Children’s Hospice; Jason D. Pole, Pediatric Oncology Group of Ontario, Toronto; Christina Vadeboncoeur, Children’s Hospital of Eastern... From the Division of General Internal Medicine, Department of Medicine; Department of Oncology, Johns Hopkins School of Medicine; Department of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; and Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA From the Departments of Public Health and Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam; Eindhoven Cancer Registry, Comprehensive Cancer Center South, Eindhoven, the Netherlands; and the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Ontario, Canada J. Frank Wharam, Fang Zhang, Christine Y. Lu, Anita K. Wagner, Stephen B. Soumerai, and Dennis Ross-Degnan, Harvard Medical School and Harvard Pilgrim Health Care Institute; Larissa Nekhlyudov, Dana-Farber Cancer Institute; Boston, MA; and Craig C. Earle, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. Odette Cancer Centre, Sunnybrook Health Sciences Centre; Institute for Clinical Evaluative Sciences; University of Toronto; Sunnybrook Health Sciences Centre; Mount Sinai Hospital, Temmy Latner Centre for Palliative Care; University Health Network, Princess Margaret Hospital, Toronto; McMaster University, Hamilton; and Queen’s University, Kingston, Ontario, Canada From the Harvard School of Public Health; Center for Outcomes and Policy Research, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and Institute of Clinical Evaluative Sciences, Toronto, Ontario, Canada. Harvard Medical School; Center for Outcomes and Policy Research, Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA. Cancer Care Ontario; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre; University of Toronto; Institute for Clinical and Evaluative Sciences; Health Outcomes and PharmacoEconomics (HOPE) Research Centre; Ontario Institute for Cancer Research, Toronto; and Juravinski Cancer Centre, Hamilton, Ontario, Canada |
Incoming Links
Total number of triples: 399.